Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Epiminder’s Minder Procedure Wins 13% Medicare Payment Increase

EPI: $0.265 +10.42% · MC: $61M

US Medicare has increased the national hospital outpatient payment for Epiminder’s Minder implant procedure by 13% for calendar 2027. The payment covers hospital procedure costs, including the device, and is adjusted for local wages; it is not revenue paid directly to Epiminder. The decision follows last week’s FDA clearance expanding Minder’s use to adolescents with drug-resistant epilepsy. Epiminder expects enrolment in its DETECT study to reach 125 participants by December, up from 100 in mid-October.

Source announcements: 2026-11-06 09:51 to 2026-11-06 09:51 Sydney time
Story updated 2026-11-06 12:06 Sydney time
SourcesCMS Increases Medicare Payment for the Minder System CY 2027
Comments